EQS-News: Marinomed Biotech AG

/ Key word(s): Miscellaneous

Marinomed focuses on growth after successful restructuring

27.03.2025 / 07:45 CET/CEST

The issuer is solely responsible for the content of this announcement.

Marinomed…Read More

You might also be interested in reading Impinj anticipates Q1 2025 revenue of $70M-$73M amid inventory headwinds and geopolitical challenges.